1086381-26-1Relevant articles and documents
1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE DERIVATIVE AS WEE1 INHIBITOR
-
Paragraph 0311-0313, (2019/12/09)
The present invention provides a 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one compound having an inhibitory effect on Wee 1, and includes an application of the compound in treating various types of tumors.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 0651-0653, (2019/04/25)
Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF
-
Paragraph 0198; 0199, (2013/06/28)
This invention relates to novel alkyne-bridged hetero-aromatics as described in the specification which are PDE10A inhibitors and useful for the treatment of neurological, psychiatric disorder, metabolic disorders, such as Schizophrenia, Parkinson's disea